Title |
The social value of clinical research
|
---|---|
Published in |
BMC Medical Ethics, September 2014
|
DOI | 10.1186/1472-6939-15-66 |
Pubmed ID | |
Authors |
Michelle GJL Habets, Johannes JM van Delden, Annelien L Bredenoord |
Abstract |
International documents on ethical conduct in clinical research have in common the principle that potential harms to research participants must be proportional to anticipated benefits. The anticipated benefits that can justify human research consist of direct benefits to the research participant, and societal benefits, also called social value. In first-in-human research, no direct benefits are expected and the benefit component of the risks-benefit assessment thus merely exists in social value. The concept social value is ambiguous by nature and is used in numerous ways in the research ethics literature. Because social value justifies involving human participants, especially in early human trials, this is problematic. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 25% |
Netherlands | 1 | 13% |
Unknown | 5 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Scientists | 2 | 25% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 94 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 19% |
Student > Ph. D. Student | 9 | 10% |
Researcher | 7 | 7% |
Student > Bachelor | 7 | 7% |
Student > Doctoral Student | 6 | 6% |
Other | 20 | 21% |
Unknown | 27 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 16% |
Arts and Humanities | 9 | 10% |
Nursing and Health Professions | 8 | 9% |
Philosophy | 5 | 5% |
Social Sciences | 5 | 5% |
Other | 22 | 23% |
Unknown | 30 | 32% |